First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

ASA to appeal Caster Semenya testosterone ruling



ASA to appeal Caster Semenya testosterone ruling

Caster Semenya of South Africa reacts after winning the women's 800m race during the Weltklasse IAAF Diamond League international athletics meeting in Zurich, Switzerland, 30 August 2018 (reissued 01 May 2019). The Court of Arbitration for Sport (CAS) announced in Lausanne, Switzerland on 01 May 2019, that it has dismissed Semenya's requests for arbitration to halt the introduction of regulations to reduce testosterone levels in female athletes with differences in sexual development (DSDs). EPA-EFE/ENNIO LEANZA
By News24
13 May 2019 0

Cape Town - Athletics South Africa (ASA) will appeal the court decision forcing Caster Semenya to take medication to lower her natural levels of testosterone.

This comes after the Court for Arbitration of Sport (CAS) approved the ruling from the IAAF that female athletes in races between 800m and a mile gain an unfair advantage from having elevated levels of testosterone.

The ruling directly impacts Semenya, who is a double Olympic champion in the 800m.

ASA had until the end of May to decide if they would appeal the decision, and it was confirmed on Monday that they would be moving ahead with that process.

In the appeal, ASA has requested the recusal of two of the arbitrators who had worked on the initial hearing while the scientific findings presented in the case have also been questioned.

According to a statement from the department of sport and recreation, the appeal was based on the following:

1) ASA applied for recusal of two of the arbitrators who it felt they were conflicted since they have handled the earlier case of the Indian sprinter, Dutee Chand as Caster was also going to be an affected athlete.

2) The strength of scientific, medical and legal case we presented, we believe, the outcome is inconceivable on the fact. The facts before court and the outcome do not match.

3) The pertinent legal questions that the court should have addressed we not addressed. The court simply gave the unfettered latitude to the IAAF to do as it pleases. For instance, it has not been answered as to how the IAAF will implement the regulations and how ethical issues will be addressed.



Please peer review 3 community comments before your comment can be posted